Bausch Health Companies Inc. (BHC)
A+
Pipeline Grade
Financial Position (from SEC Filings)
$1,312.0M
Cash & Equivalents
$230.0M
Quarterly Burn Rate
$2,786M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (63 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
BUPROPION HYDROCHLORIDE
WELLBUTRIN XL |
APPROVED | — |
|
CHLORDIAZEPOXIDE HYDROCHLORIDE, CLIDINIUM BROMIDE
LIBRAX |
APPROVED | — |
|
PYRIDOSTIGMINE BROMIDE
MESTINON |
APPROVED | — |
|
IPRATROPIUM BROMIDE
IPRATROPIUM BROMIDE |
APPROVED | — |
|
TAZAROTENE
ARAZLO |
APPROVED | — |
|
FLUCYTOSINE
ANCOBON |
APPROVED | — |
|
TETRABENAZINE
XENAZINE |
APPROVED | — |
|
IMIQUIMOD
ALDARA |
APPROVED | — |
|
HALOBETASOL PROPIONATE
BRYHALI |
APPROVED | — |
|
BEXAROTENE
TARGRETIN |
APPROVED | — |
|
BUPROPION HYDROBROMIDE
APLENZIN |
APPROVED | — |
|
ACYCLOVIR, HYDROCORTISONE
XERESE |
APPROVED | — |
|
METHOXSALEN
OXSORALEN-ULTRA |
APPROVED | — |
|
TOLCAPONE
TASMAR |
APPROVED | — |
|
METYROSINE
DEMSER |
APPROVED | — |
|
SELEGILINE HYDROCHLORIDE
ZELAPAR |
APPROVED | — |
|
HALOBETASOL PROPIONATE, TAZAROTENE
DUOBRII |
APPROVED | — |
|
TRETINOIN
RETIN-A |
APPROVED | — |
|
ADAPALENE, BENZOYL PEROXIDE, CLINDAMYCIN PHOSPHATE
CABTREO |
APPROVED | — |
|
ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE
VASERETIC |
APPROVED | — |
|
LULICONAZOLE
LUZU |
APPROVED | — |
|
ALBUTEROL SULFATE
ALBUTEROL SULFATE |
APPROVED | — |
|
CLINDAMYCIN PHOSPHATE, TRETINOIN
ZIANA |
APPROVED | — |
|
LORAZEPAM
ATIVAN |
APPROVED | — |
|
FLUOCINONIDE
VANOS |
APPROVED | — |
|
ETHACRYNATE SODIUM
EDECRIN |
APPROVED | — |
|
DILTIAZEM HYDROCHLORIDE
TIAZAC |
APPROVED | — |
|
GRISEOFULVIN, ULTRAMICROSIZE
GRIS-PEG |
APPROVED | — |
|
DIHYDROERGOTAMINE MESYLATE
D.H.E. 45 |
APPROVED | — |
|
ETHACRYNIC ACID
EDECRIN |
APPROVED | — |
|
TRIENTINE HYDROCHLORIDE
SYPRINE |
APPROVED | — |
|
PHYTONADIONE
MEPHYTON |
APPROVED | — |
|
ENALAPRIL MALEATE
VASOTEC |
APPROVED | — |
|
EFINACONAZOLE
JUBLIA |
APPROVED | — |
|
PIMECROLIMUS
ELIDEL |
APPROVED | — |
|
FLUNISOLIDE
FLUNISOLIDE |
APPROVED | — |
|
FAMOTIDINE
PEPCID |
NDA | — |
|
SODIUM BENZOATE, SODIUM PHENYLACETATE
AMMONUL |
NDA | — |
|
DESIRUDIN RECOMBINANT
IPRIVASK |
NDA | — |
|
EDETATE CALCIUM DISODIUM
CALCIUM DISODIUM VERSENATE |
NDA | — |
|
PIRBUTEROL ACETATE
MAXAIR |
NDA | — |
|
BENZOYL PEROXIDE, CLINDAMYCIN PHOSPHATE
ONEXTON |
NDA | — |
|
PENTOXIFYLLINE
PENTOXIFYLLINE |
NDA | — |
|
NABILONE
CESAMET |
NDA | — |
|
ACYCLOVIR
ZOVIRAX |
NDA | — |
|
NITROGLYCERIN
MINITRAN |
NDA | — |
|
FENOFIBRATE
FENOFIBRATE |
NDA | — |
|
ISOSORBIDE DINITRATE
ISORDIL |
NDA | — |
|
SULFACETAMIDE SODIUM
KLARON |
NDA | — |
|
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE |
NDA | — |
|
CHLORDIAZEPOXIDE HYDROCHLORIDE
LIBRIUM |
NDA | — |
|
METRONIDAZOLE
NORITATE |
NDA | — |
|
ISOPROTERENOL HYDROCHLORIDE
ISUPREL |
NDA | — |
|
PHENDIMETRAZINE TARTRATE
BONTRIL PDM |
NDA | — |
|
CROMOLYN SODIUM
CROMOLYN SODIUM |
NDA | — |
|
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE |
NDA | — |
|
RIBAVIRIN
VIRAZOLE |
NDA | — |
|
METHYLTESTOSTERONE
ANDROID 25 |
NDA | — |
|
ORPHENADRINE CITRATE
NORFLEX |
NDA | — |
|
HYDROCORTISONE BUTYRATE
LOCOID |
NDA | — |
|
ERYTHROMYCIN
ERYTHROMYCIN |
NDA | — |
|
ASPIRIN, CAFFEINE, ORPHENADRINE CITRATE
NORGESIC |
NDA | — |
|
CICLOPIROX
LOPROX |
NDA | — |
Upcoming Catalysts
No upcoming catalysts detected for this company.